Core Scientific (CORZ) Insider M Sells $151K of Stock

Core Scientific, Inc. (CORZ) faced insider trading activity on October 12, 2026, as Todd Duchene, the Chief Legal and Administrative Officer, sold 10,000 shares at a price of $15.12 each. This sale was part of a planned transaction and totaled $151,160.

Inside Duchene's Trade

Duchene's sale brings his total to 40,000 shares sold in recent weeks. Earlier, he sold 10,000 shares on October 5 at $15.12, 10,000 shares on September 28 at $16.76, and 10,000 shares on September 21 at $18.37. The latest transaction occurred on the same day as his previous sale, indicating a consistent strategy to reduce his holdings.

Other Institutional Activity in Core Scientific

Blackrock Inc. increased its stake in Core Scientific by 3,492,500 shares, ending with 28,122,262 shares valued at approximately $379.1 million. Jericho Capital Asset Management, LP added 11,159,523 shares to its position, bringing its total to 22,882,942 shares worth about $308.5 million. Meanwhile, UBS Group AG reduced its holdings by 9,644,002 shares, ending with 15,889,496 shares valued at around $214.2 million.

Core Scientific, Inc. Stock Up 0.3%

Core Scientific's stock recently traded around $13.54 as of October 16, 2026, which is 55.5% below its 52-week high of $30.46. The shares are currently below both the 50-day and 200-day moving averages, by 23.3% and 31.6%, respectively. This decline in stock price comes despite a strong revenue growth rate of 108.8% year-over-year.

Recent Earnings

Core Scientific reported trailing twelve-month revenue of $440.3 million, but it faced challenges with an EPS of -$3.72. The company is set to announce its next earnings on November 5, 2026.

Insider Buying and Selling at Core Scientific, Inc.

In addition to Duchene's recent sale, he had previously sold shares on September 21 for $183,746, on September 28 for $167,586, and on October 5 for $163,056. Each of these transactions was executed before the latest sale on October 12.

Analysts Set New Price Targets

On October 14, 2026, Cantor Fitzgerald reiterated its "Overweight" rating on Core Scientific with a price target of $39. Earlier, B. Riley Securities maintained a "Buy" rating with a target of $42. The consensus among analysts suggests a strong buy rating with a mean price target of $33.05 based on 21 opinions.

About Core Scientific, Inc.

Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States. The company operates through three segments: Colocation, Digital Asset Self-Mining, and Digital Asset Hosted Mining. Its recent trading activity and strong revenue growth highlight the company's positioning in the technology sector.

Bottom Line

Investors will be watching for Core Scientific's upcoming earnings report on November 5, 2026, to gauge its financial health amid recent insider activity. Duchene's planned sales reflect a broader trend of insider trading as the company navigates its growth in the technology sector.